The trademark IJECT was filed by Bioject, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 19, 2007, and received one opposition filed on October 15, 2007 by Sanofi-Aventis Deutschland GmbH on Likelihood of confusion. the opponent was represented by FPS PARTNERSCHAFT VON RECHTSANWÄLTEN MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 15, 2007
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).